News
Tirzepatide First-Line Status: ACP Obesity Guid...
ACP's 2025 guidelines elevate tirzepatide to first-line obesity treatment. We examine dosing protocols, female-specific metabolic considerations, and unanswered questions in reproductive-age cohorts.
Tirzepatide First-Line Status: ACP Obesity Guid...
ACP's 2025 guidelines elevate tirzepatide to first-line obesity treatment. We examine dosing protocols, female-specific metabolic considerations, and unanswered questions in reproductive-age cohorts.